Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Delivering drugs to CNS tumours: techniques and challenges

Drug Delivery in Paediatric Brain Tumours

Published: 8 Feb 2016

Views: 2678

Rating:

Save

Dr Kathy Warren - National Cancer Institute, Washington, USA

Dr Warren talks to ecancertv at Children with Cancer UK’s workshop on Drug Delivery in Paediatric Brain Tumours in London, UK.

In the interview she discusses her research at the National Cancer Institute.

This includes using improved drug delivery methods to find an effective local treatment for diffuse intrinsic pontine glioma (DIPG) and improved models of preclinical testing.

Related Videos

Addressing the rise of multiple myeloma in Rwanda

Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda

Addressing the rise of multiple myeloma in Rwanda ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )

GIST tumours and soft tissue sarcomas

Dr Atif Hussein - Memorial Cancer Institute, Miami, USA

GIST tumours and soft tissue sarcomas ( Dr Atif Hussein - Memorial Cancer Institute, Miami, USA )

Importance of MRD in newly developed multiple myeloma

Prof Xavier Leleu - Poitiers Centre Hospitalier Universitaire, Poitiers, France

Importance of MRD in newly developed multiple myeloma ( Prof Xavier Leleu - Poitiers Centre Hospitalier Universitaire, Poitiers, France )

Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel...

Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel Antonarakis )

The genomics of cancer in Africa

Prof Solomon Rotimi - Covenant University, Ota, Nigeria

The genomics of cancer in Africa ( Prof Solomon Rotimi - Covenant University, Ota, Nigeria )

Pembrolizumab benefits patients with brain metastases

Dr Priscilla Brastianos - Mass General Cancer Center, Boston, USA

Pembrolizumab benefits patients with brain metastases ( Dr Priscilla Brastianos - Mass General Cancer Center, Boston, USA )

Nivolumab-AVD reduces the risk of disease progression compared to brentuximab...

Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA

Nivolumab-AVD reduces the risk of disease progression compared to brentuximab vedotin-AVD in advanced Hodgkin lymphoma ( Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA )

The current status of multiple myeloma diagnosis and treatment

Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina

The current status of multiple myeloma diagnosis and treatment ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA...

Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer...

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours ( Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK )

More from ecancer